|
16th GAVI BOARD MEETING
Paris, France, 19-20 July, 2005
Summary Report
|
|
>>Back to the 16th GAVI Board Meeting
|
|
Documents
Presentation - Long-tem supply and procurement strategy: Donald Strombom, Consultant (
PPT - 581K)
Presentation - Update on supplier study: Wendy Woods, Boston Consulting Group (
PPT - 237K)
Presentation - Next steps: David Fleming (
PPT - 53K)
Global Vaccine Supply: the Changing Role of Suppliers (
PDF - 36K)
GAVI/VF Long-term supply strategy (
PDF - 38K)
|
|
7. Long-term supply and procurement strategy
- In the near-term it will be important to focus on Hib
and hepB-containing products; supply strategies for potential future
vaccines cannot be determined until more information becomes available.
- The procurement process will need to be underway
by early 2006 so the work to develop the supply strategy should be
‘turbo-charged’.
- Experience has shown that policies aimed at
quickly reducing prices may not encourage entry of additional
manufacturers and long-term sustainable supply.
- From the increased number of Hib and
hepB-containing combination vaccines currently in the pipeline, we can
see that in its first phase GAVI has indeed been a ‘market shaper’.
- Strategies must be developed such that they do
not encourage production beyond reasonable demand. Careful attention
must be paid to forecasting, and the supply task team must involve
experts with direct experience in buying and manufacturing.
DECISIONS
The Board:
Endorsed the proposal to create a small task team of
GAVI partners that would begin work immediately to lead the next steps
on the supply strategy for Hib and hepB combination vaccines. The
Secretariat should engage a consultant to support the task team.
Expressed concern at the slow progress in this area and
insisted that the work of this team move quickly, with a progress
report to the joint Executive Committee meeting in September. The final
recommendations will be presented for Board approval in December.
The recommendations of the task team will be shared with an independent expert review team.
|
|
>>Back to the 16th GAVI Board Meeting
|
| |
|
|
Go
here for presentations
Go
here for documents
Topics:
-
Report from the field: Malawi
-
GAVI/Vaccine Fund in Phase 2—Executive Secretary Report
-
Investment case development, review and decision-making process
-
Bridge financing investment case
-
New vaccines in phase 2
-
IFFIm-Dependent Investment Cases
-
Long-term supply and procurement strategy
-
The International Finance Facility for Immunization
-
Immunization services support and health system strengthening
-
Technical support in phase 2
-
GAVI/VF 2006-07 Work Plan Framework
-
Yellow fever stockpile evaluation
|
|